SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

More documents

Recommendations

Info

G L O S S A R Y G L O S S A R Y 2-DG—2 deoxyglucose ACDU—Automatic Cell Deposition Unit ACS—American Cancer Society ALL—acute lymphocytic leukemia AMC—AIDS Malignancy Consortium AML—acute myeloid leukemia APC—antigen presenting cell ATL—adult T-cell leukemia AZT—azidothymidine BEA—blastocyst engraftment assay BF—benefit-finding BMT—bone marrow transplantation CBSM—cognitive-behavioral stress management CBCTR—Cooperative Breast Cancer Tissue Resource CDC—Centers for Disease Control Cdk—cyclin-dependent kinase CK—cytokeratin CLL—chronic lymphocytic leukemia CMT—chemically-modified tetracycline CNS—central nervous system COL-3—chemically modified non-antimicrobial tetracycline CPOR—Center for Psycho-Oncology Research CPT—natural product camptothecin CTL—cytotoxic T lymphocytes DC—dendritic cells DLBCL—diffuse large B-cell lymphoma DR3—death receptor 3 DSMB—Data and Safety Monitoring Plan EBV—Epstein-Barr virus ECM—extracellular matrix EGF—epidermal growth factor EMSA—electromobility shift assay ER—estrogen receptor ERM—ezrin, radixin, and moesin ER/PR—estrogen receptor/progesterone receptor ES—embryonic stem EST—expressed sequence tag FAMRI—Flight Attendant Medical Research Institute FDA—Food and Drug Administration FCCCI—Florida Comprehensive Cancer Control Initiative FCDS—Florida Cancer Data System FDOH—Florida Department of Health FLRF—fetal liver ring finger FRAP—fluorescence recovery after photo bleaching FRET—fluorescence resonance energy transfer GC—germinal center GCRC—General Clinical Research Center GI—gastrointestinal GIS—geographic information system GM-CSF—granulocyte macrophage-colony stimulating factor GPI—glycosil-phosphatidil-inositil GVHD—graft versus host disease HA—hyaluronic acid HAASE—hyaluronidase HAM/TSP—HTLB-associated myelomathy/ tropical spastic paraparesis HCC—hepatocellular carcinoma HCV—hepatitis C virus HGAL—human germinal center-associated lymphoma HHV—human herpes virus HIF—hypoxic inducible factor HIV—human immunodeficiency virus HNSCC—head and neck squamous cell carcinoma HPV—human papilloma virus HSC—hematopoietic stem cells HSV—herpes simplex virus HTLV-I—human T-lymphotropic virus type I HYAL1—hyaluronidase IF—intermediate filament UM/Sylvester Comprehensive Cancer Center Scientific Report 2004 191
G L O S S A R Y IFN—interferon IL—interleukin INCA—National Cancer Institute of Brazil IND—Investigational New Drug INOS—inducible nitric oxide synthase IRB—Institutional Review Board KO—knock-out LAK—lymphokine-activated killer cells LCM—laser capture dissection microscope LSC—laser scanning cytometer MAPK—mitogen-activated protein kinase MDR—multiple drug resistance MHC—major histocompatability complex MIC-1—macrophage inflammatory cytokine-1 MIS—MetaMorph Imaging System MM—multiple myeloma MMPs—matrix metalloproteinases mRNA—messenger RNA mtDNA—human mitochondrial DNA MTOC—microtubule organizing centers MUC1—human mucin 1 NASA—National Aeronautics and Space Administration NCI—National Cancer Institute NCI-DTP—National Cancer Institute- Developmental Therapeutics Program NGF—nerve growth factor NHL—non-Hodgkin lymphoma NHLBL—National Heart, Lung, and Blood Institute NIEHS—National Institute of Environmental Health Sciences NIH—National Institutes of Health NIOSH—National Institute of Occupational Safety and Health NK—natural killer NKB—Dutch Cancer Foundation NKCC—natural killer cell cytotoxicity NMR—nuclear magnetic resonance NO—nitric oxide NPC—nuclear pore complexes Nups—nucleoporins ORF—open reading frame OXPHOS—oxidative phosphorylation PCMR—Pediatric Cardiomyopathy Registry PCNA—proliferating cell nuclear antigen PCR—polymerase chain reaction PDIP1—polymerase delta interacting protein-1 PDK1—phosphoinositide-dependent protein kinase-1 PEL—primary effusion lymphomas PEMs—peritoneal elicited macrophages PGCs—primordial germ cells PH—pleckstrin homology PKB—protein kinase B PKC—protein kinase C Polε—polymerase epsilon QLACS—quality of life in adult cancer survivors Rb—retinoblastoma RENCA—renal cell carcinoma RT—reverse transcriptase RTOG—Radiation Therapy Oncology Group SCCA—squamous cell carcinoma SCID—severe combined immunodeficiency disease SIL—squamous intraepithelial lesions SIR—standardized incidence ratios SMC—sialomucin complex TBIO—thermodynamically balanced inside-out TGF-α—transforming growth factor-alpha TGF-β—transforming growth factor-beta TNF—tumor necrosis factor UM/Sylvester—University of Miami Sylvester Comprehensive Cancer Center VEGF—vascular endothelial growth factor VSV—vesicular stomatitis virus wt—wild type 192 UM/Sylvester Comprehensive Cancer Center Scientific Report 2004
Page 1 and 2:
S C I E N T I F I C R E P O R T 2 0
Page 3 and 4:
I N T R O D U C T I O N A N D P R O
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
L E A D E R S H I P MULTIDISCIPLINA
Page 13 and 14:
L E A D E R S H I P EXTERNAL ADVISO
Page 15 and 16:
C A N C E R P R E V E N T I O N A N
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
C L I N I C A L O N C O L O G Y R E
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
T U M O R C E L L B I O L O G Y P R
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
T U M O R I M M U N O L O G Y P R O
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
V I R A L O N C O L O G Y P R O G R
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154: V I R A L O N C O L O G Y P R O G R
Page 155 and 156: V I R A L O N C O L O G Y P R O G R
Page 157 and 158: S H A R E D R E S O U R C E S 3) La
Page 159 and 160: S H A R E D R E S O U R C E S C E L
Page 161 and 162: S H A R E D R E S O U R C E S D N A
Page 163 and 164: S H A R E D R E S O U R C E S G E N
Page 165 and 166: S H A R E D R E S O U R C E S I N F
Page 167 and 168: S H A R E D R E S O U R C E S P O P
Page 169 and 170: P U B L I C A T I O N S 2 0 0 2 - 2
Page 203: P U B L I C A T I O N S 2 0 0 2 - 2
show all

SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

Create successful ePaper yourself

Delete template?

Save as template?